Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AREST-ESUS: Rivaroxaban plus Aspirin in ESUS
NCT04273516Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in embolic stroke of undetermined source (ESUS), sponsored by Mazandaran University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
embolic stroke of undetermined source (ESUS)
Beyond the preview
Go deeper on NCT04273516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273516.